Bacillus subtilis spores as adjuvants for DNA vaccines
Recently, Bacillus subtilis spores were shown to be endowed with strong adjuvant capacity when co-administered with purified antigenic proteins. In the present study we assessed whether spores possess adjuvant properties when combined with DNA vaccines. We showed that B. subtilis spores promoted the activation of dendritic cells in vitro and induced migration of pro-inflammatory cells after parenteral administration to mice. Likewise, co-administration of spores with a DNA vaccine encoding the human papillomavirus type 16 (HPV-16) E7 protein enhanced the activation of antigen-specific CD8(+) T cell responses in vivo. Mice immunized with the DNA vaccine admixed with spores presented a protective immunity increase to previously implanted tumor cells, capable of expressing HPV-16 oncoproteins. Finally, we observed that the adjuvant effect can vary accordingly to the number of co-administered spores which may be ascribed with the ability to induce. Collectively, the present results demonstrate for the first time that B. subtilis spores can also confer adjuvant effects to DNA vaccines..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Vaccine - 33(2015), 20, Seite 2328-2334 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aps, Luana R M M [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1016/j.vaccine.2015.03.043 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1956707603 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1956707603 | ||
| 003 | DE-627 | ||
| 005 | 20230714141741.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.vaccine.2015.03.043 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1956707603 | ||
| 035 | |a (DE-599)GBVOLC1956707603 | ||
| 035 | |a (PRQ)c1296-d2558f2a44c1202720d493ed566ab19e6579650481bb969ebd2a2cbf7ceb64500 | ||
| 035 | |a (KEY)0128923320150000033002002328bacillussubtilissporesasadjuvantsfordnavaccines | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Aps, Luana R M M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bacillus subtilis spores as adjuvants for DNA vaccines |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Recently, Bacillus subtilis spores were shown to be endowed with strong adjuvant capacity when co-administered with purified antigenic proteins. In the present study we assessed whether spores possess adjuvant properties when combined with DNA vaccines. We showed that B. subtilis spores promoted the activation of dendritic cells in vitro and induced migration of pro-inflammatory cells after parenteral administration to mice. Likewise, co-administration of spores with a DNA vaccine encoding the human papillomavirus type 16 (HPV-16) E7 protein enhanced the activation of antigen-specific CD8(+) T cell responses in vivo. Mice immunized with the DNA vaccine admixed with spores presented a protective immunity increase to previously implanted tumor cells, capable of expressing HPV-16 oncoproteins. Finally, we observed that the adjuvant effect can vary accordingly to the number of co-administered spores which may be ascribed with the ability to induce. Collectively, the present results demonstrate for the first time that B. subtilis spores can also confer adjuvant effects to DNA vaccines. | ||
| 540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Ltd. All rights reserved. | ||
| 650 | 4 | |a Bacillus subtilis - physiology | |
| 650 | 4 | |a Vaccines, DNA - immunology | |
| 650 | 4 | |a Papillomavirus E7 Proteins - genetics | |
| 650 | 4 | |a Spores, Bacterial - immunology | |
| 650 | 4 | |a Adjuvants, Immunologic - administration & dosage | |
| 650 | 4 | |a CD8-Positive T-Lymphocytes - immunology | |
| 650 | 4 | |a Bacillus subtilis - immunology | |
| 650 | 4 | |a Dendritic Cells - immunology | |
| 650 | 4 | |a Vaccines, DNA - administration & dosage | |
| 650 | 4 | |a Cytokines - immunology | |
| 650 | 4 | |a Interferon-gamma - immunology | |
| 650 | 4 | |a Papillomavirus E7 Proteins - immunology | |
| 700 | 1 | |a Diniz, Mariana O |4 oth | |
| 700 | 1 | |a Porchia, Bruna F M M |4 oth | |
| 700 | 1 | |a Sales, Natiely S |4 oth | |
| 700 | 1 | |a Moreno, Ana Carolina R |4 oth | |
| 700 | 1 | |a Ferreira, Luís C S |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Vaccine |d Amsterdam : Elsevier, 1983 |g 33(2015), 20, Seite 2328-2334 |w (DE-627)130402427 |w (DE-600)605674-X |w (DE-576)015904938 |x 0264-410X |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2015 |g number:20 |g pages:2328-2334 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.vaccine.2015.03.043 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25819710 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2015 |e 20 |h 2328-2334 | ||